Rating: HOLD
HOLD (5-tier) · mature cash generator · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $97 |
| Triangulated Fair Value | $81 (-16% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $91 (-6% vs spot · 12m PWEV) |
| Forward P/E | 42.0x |
| Market Cap | $95B |
| 52-Week Range | $58–$96 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | HOLD · HOLD (5-tier) |
| Classification · conviction | mature cash generator · medium |
| Triangulated fair value | $81 (-16% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $91 (-6% vs spot · 12m PWEV) |
| Next catalyst | 2026-08-06 — Quarterly earnings |
| Primary thesis-break | Global volume growth (case-equivalent, y/y) below 0.02 (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -6% vs spot
- Monte Carlo median implies -12% vs spot
- DCF fair value implies -25% vs spot — but this is terminal-value sensitive (exit-multiple $73 vs Gordon $58, 20% apart), so it carries less weight
- Bear case (Structural — GLP-1 Volume Hit / De-Rate) downside is -58% vs spot
- Net: reward/risk of 0.3× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Investment Thesis
At $96.12 on a roughly 41x forward multiple, the market prices Monster as a durable premium compounder: mid-single-digit volume, price/mix intact, and margins near 31%, with GLP-1 treated as noise rather than a demand threat. The engine is less convinced. Probability-weighting the five scenarios yields a target of $94.71, essentially the current price, because the P/E multiple carries roughly 76% of Monte Carlo variance while revenue growth carries under 4%. The rating is HOLD: earnings can compound in the Base and Growth paths, but the valuation already discounts that, and the DCF anchor of $74.72 sits well below spot. Peer-median forward multiples imply closer to $37, a gap the premium can justify only if growth and margin persist. Net cash of $2.04B and a capital-light ~$0.13B FY2025 capex base support the quality read. The single most damaging risk is a structural GLP-1 volume impairment: the Structural path compresses margin to 23.5% and the multiple to 24x, producing a $45 target beneath the 52-week low of $58.09.
The dashboard below is the whole argument on one page: spot ($97) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear scenario is a structural GLP-1 and private-label volume hit, which the cluster weights at 40%. The mechanism is not a single weak quarter but a durable reduction in energy-drink consumption occasions as appetite-suppressing therapies scale across the consumer base. Volume stalls, price/mix can no longer offset it, and operating deleverage drags margin from 31.1% toward the mid-20s. Critically, earnings compression and multiple compression compound: a beverage franchise growing volumes at zero does not command 41x, and the multiple de-rates toward a low-growth staple near 24x. That combination produces a target around $41, below the 52-week low. With the multiple driving three-quarters of outcome variance, this is where the real downside lives.
Key Debate
P/E Multiple explains 76% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.46 vs analyst floor +0.00 → delta +0.46 (n=16 mgmt / 6 Q&A; 64th pctile across the S&P book, z +0.4).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.46 | +0.00 | +0.46 |
| 2025Q4 | +0.60 | +0.45 | +0.15 |
| 2025Q3 | +0.64 | +0.50 | +0.14 |
| 2025Q2 | +0.52 | +0.22 | +0.30 |
News (last 365d, 1000 articles): avg ticker sentiment +0.25 (bullish 32% / bearish 1%)
Scenario Analysis
The tree runs from a structural 'Structural — GLP-1 Volume Hit / De-Rate' downside ($41) to a 'Bull — Defensive Re-Rate' bull case ($143); the probability-weighted blend (PWEV $91) is -6% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — GLP-1 Volume Hit / De-Rate | 20% | $41 | -58% |
| Consumer / Input Recession | 17% | $79 | -19% |
| Base — Pricing + Mix Growth | 35% | $97 | +0% |
| Growth — Emerging Markets + Energy/Zero-Sugar | 20% | $122 | +25% |
| Bull — Defensive Re-Rate | 8% | $143 | +48% |
| Probability-Weighted (PWEV) | — | $91 | -6% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — GLP-1 Volume Hit / De-Rate (20%, $41). Structural impairment — GLP-1 volume hit / de-rate: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 45.46; probability: 0.2.
- Consumer / Input Recession (17%, $79). Cyclical downturn — beverage volume + pricing/mix + emerging-market growth (GLP-1 debate) weakens for 1–2 years before normalising. Drivers — implied_target: 78.62; probability: 0.17.
- Base — Pricing + Mix Growth (35%, $97). Mid-cycle — normalised beverage volume + pricing/mix + emerging-market growth (GLP-1 debate); disciplined capital allocation; steady returns. Drivers — implied_target: 100.54; probability: 0.35.
- Growth — Emerging Markets + Energy/Zero-Sugar (20%, $122). Upside — emerging markets + energy / zero-sugar lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 126.94; probability: 0.2.
- Bull — Defensive Re-Rate (8%, $143). Upside tail — sustained tight conditions or a structural re-rate on emerging markets + energy / zero-sugar. Drivers — implied_target: 145.98; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $85 | -12% |
| Peer P/E re-rate | multiple | $37 | -61% |
| Peer EV/Revenue re-rate | multiple | $37 | -61% |
| Scenario PWEV | multiple | $91 | -6% |
| DCF (5-year + terminal) | cash flow + terminal × | $73 | -25% |
| Triangulated (weighted) | — | $81 | -16% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $85 + scenario PWEV $91, ≈ spot); the weighted blend $81 (-16%) sits below it because the cash-flow DCF ($73) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $85 and 35% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (76% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 7.0%, 30x terminal FCF multiple → $73. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 16.23x) implies $37. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 74% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Non-Alcoholic Beverages | $8.8B | 100% | 5% | 31% | $2.7B | 41x | 5% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | beverage volume + pricing/mix + emerging-market growth (GLP-1 debate) |
| net_debt_or_cash_b | 2.04 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.05 |
| div_yield | None |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | GLP-1 volume hit / de-rate |
| upside | emerging markets + energy / zero-sugar |
Industry Context — Consumer Staples — Food Bev
This name sits in the Consumer Staples — Food Bev as a beverages. beverage volume + pricing/mix + emerging-market growth (GLP-1 debate) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: KO (beverages) · PEP (beverages) · MNST (beverages) · MDLZ (packaged_food) · KDP (beverages) · HSY (packaged_food) · KHC (packaged_food) · GIS (packaged_food) · HRL (packaged_food) · MKC (packaged_food) · SJM (packaged_food) · CAG (packaged_food)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Structural — GLP-1 / Private-Label Volume Hit | 40% | 37% | |
| Mid-Cycle — Price/Mix Offsets Volume | 33% | 35% | |
| Upside — Premiumization / EM Growth | 27% | 28% |
Mapping note: name-level 'Structural — GLP-1 Volume Hit / De-Rate' (20%) + 'Consumer / Input Recession' (17%) map to cluster Structural — GLP-1 / Private-Label Volume Hit (37%); name-level 'Growth — Emerging Markets + Energy/Zero-Sugar' (20%) + 'Bull — Defensive Re-Rate' (8%) map to cluster Upside — Premiumization / EM Growth (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Structural — GLP-1 / Private-Label Volume Hit () — this name implies 37% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_food_bev cycle is the shared macro driver. Driver — food & beverage volume + price/mix vs private-label + GLP-1 + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $9B | $3B | $0B | $0B | $2B | $2B |
| FY+2 | $10B | $3B | $0B | $0B | $2B | $2B |
| FY+3 | $10B | $3B | $0B | $0B | $3B | $2B |
| FY+4 | $10B | $4B | $0B | $0B | $3B | $2B |
| FY+5 | $11B | $4B | $0B | $0B | $3B | $2B |
| Terminal | — | — | — | — | $3B × 30x | $59B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 5% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 7.0% · Σ PV(FCF) $10B + PV(terminal) $59B = EV $69B; + net cash → equity $71B ÷ diluted shares 0.98B = $73/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $58/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 42% vs WACC 7% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| KO | 7.65x | 24.75x | 5% | 35% |
| PEP | 2.437x | 16.23x | 5% | 17% |
| KDP | 3.943x | 13.42x | 5% | 19% |
| Median | 3.943x | 16.23x | — | — |
Peer-median fwd P/E → $37; EV/Rev → $37.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $73 | 47% | $34 |
| Scenario PWEV | $91 | 33% | $30 |
| Monte Carlo median | $85 | 20% | $17 |
| Triangulated | — | 100% | $81 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 21.0x | 25.5x | 30.0x | 34.5x | 39.0x |
|---|---|---|---|---|---|
| 5% | $59 | $69 | $79 | $89 | $99 |
| 6% | $57 | $66 | $76 | $85 | $95 |
| 7% | $55 | $64 | $73 | $82 | $90 |
| 8% | $52 | $61 | $70 | $78 | $87 |
| 9% | $50 | $58 | $67 | $75 | $83 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $57 | $60 | $63 | $66 | $69 |
| -1.5pp | $62 | $65 | $68 | $71 | $74 |
| +0.0pp | $66 | $69 | $73 | $76 | $79 |
| +1.5pp | $71 | $74 | $78 | $81 | $85 |
| +3.0pp | $75 | $79 | $83 | $87 | $91 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $63 | $83 | $20 |
| Terminal × ±15% | $64 | $82 | $18 |
| Op margin ±3pp | $66 | $79 | $13 |
| WACC ±1pp | $70 | $76 | $6 |
| Capex intensity ±15% | $71 | $74 | $3 |
Company lever — SoP/share vs Non-Alcoholic Beverages multiple (AI re-rating) (base 41x)
| Multiple | 28.7x | 34.9x | 41.0x | 47.1x | 53.3x |
|---|---|---|---|---|---|
| SoP/share | $260 | $316 | $371 | $426 | $482 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $90 (-8% vs spot · street) |
| House target | $95 (+5.6% vs street) |
| Sell-side coverage | 26 analysts (SB 3 / B 12 / H 10 / S 1 / SS 0; net score 0.33) |
| Consensus FY EPS | $2.56; house below (-9.6%) |
| Consensus FY revenue | $10.3B; house below (-11.0%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $-2.8B — net cash |
| Net debt / EBITDA | -0.98x |
| Interest coverage (EBIT / interest) | 355.6x |
| Current ratio | 3.70x |
| Cash & ST investments | $2.8B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $2.0B |
| Buybacks / dividends | $0.1B / $0.0B |
| Total shareholder yield | 0.1% |
| Payout as % of FCF | 5.3% |
| Reinvestment (capex / OCF) | 6.3% |
| SBC as % of FCF | 6.4% |
| Allocation stance | reinvesting |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 22.3% |
| FCF conversion (FCF / net income) | 103.2% |
| FCF yield | 2.1% |
| Capex intensity (capex / revenue) | 1.5% |
| FCF − SBC (diagnostic) | $1.8B |
| Capex split (maint / growth) | 60% / 40% — Asset-light beverage model (distribution outsourced to Coca-Cola); the schedule ramp reflects co-packing capacity, international footprint and the alcohol/AFF adjacency as the growth slug. |
Accounting quality: SBC 1.4% of revenue; cash conversion (OCF/NI) 110% — cash-backed.
Catalyst Calendar
- 2026-08-06 (~29d) — Quarterly earnings — est. EPS $0.59 (AV EARNINGS_CALENDAR)
- 2026-09-15 (~69d) — Aluminum / input-cost and pricing-action update (authored)
- 2026-10-30 (~114d) — International expansion / new-market launch cadence update (authored)
- 2027-01-31 (~207d) — Alcohol (Beast/flavored-malt) and new-format portfolio traction (authored)
Forecast Track Record
- EPS surprise: beat 50.0% of the last 8 quarters; average surprise -3.2%.
Competitive Moat
Wide moat. Monster's moat is brand equity in energy drinks plus the Coca-Cola global distribution agreement - a genuine scale/access advantage rivals cannot replicate; this supports a premium multiple. But ~41x forward already prices durability; if GLP-1 or private-label energy erodes volume, the terminal multiple should compress toward the beverage-peer range (~22-25x).
Moat sources:
- Leading energy-drink brand equity and shelf velocity in a high-margin category
- Coca-Cola bottler distribution agreement - irreplaceable global route-to-market
- Scale advantage in a duopoly-like energy category vs sub-scale entrants
- Pricing power and mix (zero-sugar, energy) supporting ~31% margins
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Caffeine content / energy-drink marketing-to-minors regulation | medium (~35%) | medium - labeling/age limits on a core category ~4-6% of FV | 12-24m |
| Sugar/beverage taxes in international growth markets | medium (~40%) | low - partly offset by zero-sugar mix shift ~2-3% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — GLP-1 Volume Hit / De-Rate | GLP-1 adoption durably cuts energy-drink consumption occasions while private-label energy gains shelf share | A ~41x multiple with impaired volume growth compresses violently; the re-rating risk dwarfs the earnings hit |
| Consumer / Input Recession | Consumer trade-down plus aluminum/input inflation squeezes volume and gross margin together | Premium positioning is vulnerable to value substitution in a downturn while costs rise |
| Base — Pricing + Mix Growth | Mid-single-digit volume with price/mix and zero-sugar shift holding ~31% margin | The premium multiple leaves no room for a volume miss; deceleration alone triggers de-rating |
| Growth — Emerging Markets + Energy/Zero-Sugar | Emerging-market penetration and zero-sugar/energy mix drive above-trend volume and margin | FX and distribution execution in new markets can strand the growth investment |
| Bull — Defensive Re-Rate | GLP-1 fears fade, category durability is proven, and the market re-rates the compounder further | Little upside left at 41x; a bull re-rate needs a lower-rate regime plus demonstrated volume durability |
What the Market Is Pricing In
At the current price, the market pays 37.9× forward EPS, vs the house DCF terminal 30.0×, and a peer median 16.23×. The house DCF sits 25% below spot, so the market is pricing in more than the house case — roughly 2.7pp of revenue CAGR.
Variant perception: the house view is above-consensus, and the thesis is primarily FCF-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 10.3 | 9.2 | High |
| EPS | 2.6 | 2.3 | Medium |
| Target price | 89.7 | 94.7 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| KO | 24.75× | 5% | 35% | segment | 50% |
| PEP | 16.23× | 5% | 17% | broad | 25% |
| KDP | 13.42× | 5% | 19% | broad | 25% |
Quality-weighted forward P/E: 19.8× (simple median 16.23×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $58–$96, centre $75 (-23% vs spot); spot sits at the 102th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $81 (-16% vs spot · triangulated FV) |
| Downside to bear case (Structural — GLP-1 Volume Hit / De-Rate) | $41 (-58% vs spot · bear scenario) |
| Reward/risk ratio | 0.3× |
| Margin of safety (FV vs spot) | -19% |
| P(price > spot) — Monte Carlo | 35% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Defensive Re-Rate): $143.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 7.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 30× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (20.0); Terminal × ±15% (18.0); Op margin ±3pp (13.0); WACC ±1pp (6.0); Capex intensity ±15% (3.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $8.8B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $9.2B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $2.5553 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.983B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $-2.765B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 7.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 30× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-26 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-07-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 7%, terminal multiple 30×, FY+5 revenue $11B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Global volume growth (case-equivalent, y/y) below 0.02 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). The Base case assumes mid-single-digit volume. Sub-2% volume for two quarters signals GLP-1 or trade-down demand erosion rather than a one-quarter shipment timing effect, breaking the price/mix-offsets-volume thesis.
- Gross margin (reported, y/y) below -0.015 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Sustained margin contraction of >150bps year-on-year would indicate input-cost or promotional pressure that price actions are failing to recover, moving the margin path toward the Recession/Structural operating-margin assumptions.
- US energy-drink category retail-sales growth (tracked channels, y/y) below 0.0 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). A flat-to-declining domestic category read would confirm demand impairment in the core market rather than share dynamics, supporting the structural de-rate over the cyclical read.
- International net sales growth (y/y, currency-neutral) below 0.08 (2 consecutive prints → Growth — Emerging Markets + Energy/Zero-Sugar). The Growth and Bull cases rest on emerging-market volume above trend. Currency-neutral international growth falling below 8% for two prints removes the offset to a maturing US base and pulls the weighting toward Base.
- Trailing-twelve-month capital expenditure ($B) above 0.4 (single event → Base — Pricing + Mix Growth). Capex above $0.40B against a ~$0.13B FY2025 base and D&A near $0.11B would signal a capital-intensity step-up. If not matched by volume acceleration, incremental ROIC dilutes and the capital-light margin structure weakens.
Fact / Inference / Speculation
- FACT: Spot $97; 52-week range $58–$96; engine rating HOLD; base-case target $95 (-2%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
- INFERENCE: Triangulated FV $81 (-16% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: HOLD
Balanced: triangulated fair value $76 (-21% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.